Lethality-based selection of recombinant genes in mammalian cells: application to identifying tumor antigens

E S Smith1, A Mandokhot, E E Evans

  • 1Vaccinex, Inc., Rochester, New York, USA.

Nature Medicine
|August 2, 2001
PubMed

Insights

Researchers developed a new method using poxvirus vectors to create cDNA libraries from non-dividing cells. This advance enables the selection of genes involved in cell death and growth arrest, including cancer-related antigens.

Area of Science:

  • Molecular Biology
  • Immunology
  • Virology

Background:

  • Mammalian expression vectors are crucial for constructing cDNA libraries, but recovery is limited to actively dividing cells.
  • This limitation hinders the selection of genes involved in cell death or growth arrest, such as those encoding cytotoxic T-cell antigens or pro-apoptotic factors.
  • Existing methods are inefficient for isolating genes from non-proliferating cells.

Purpose of the Study:

  • To develop a novel mammalian expression vector system for constructing cDNA libraries from non-dividing cells.
  • To overcome the limitations of traditional vectors in selecting genes related to cell lethality or growth arrest.
  • To enable the efficient recovery of functional genes from cells that have undergone selection-based cell death.

Main Methods:

  • Construction of representative cDNA libraries using a poxvirus-based vector system.
  • Application of lethality-based selection to recover desired genes from non-dividing cells.
  • Utilizing the poxvirus vector for efficient gene recovery irrespective of host cell proliferation.

Main Results:

  • Successfully constructed cDNA libraries in a poxvirus-based vector that can be recovered from cells undergoing lethality-based selection.
  • Demonstrated the feasibility of selecting genes from non-proliferating cells.
  • Applied the strategy to successfully select a gene encoding a cytotoxic T-cell target antigen found in multiple tumors.

Conclusions:

  • Poxvirus-based expression vectors provide a robust platform for creating and recovering cDNA libraries from non-dividing mammalian cells.
  • This novel approach significantly enhances the efficiency of selecting genes that mediate cell death or growth arrest.
  • The strategy has direct applications in identifying key genes, such as tumor antigens, relevant to cancer immunology and therapy.